Leaders in the field of induced pluripotent stem cell (iPSC) – a technology that can help derive motor neurons from people who suffer from amyotrophic lateral sclerosis (ALS) – have published a cutting-edge review, identifying advances and challenges in ALS modeling ability and calling for the development and adoption of rigorous criteria…
1. Herantis’ Potential ALS Treatment, CDNF, Recommended for Orphan Drug Status by EMA Herantis Pharma announced that it has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) on…
In this cauchilab video, “Cyrielle Delmas meets graduate Rebecca Borg at her Dr. Cauchi’s lab at the University of Malta to talk about her research on ways to cure ALS/motor neuron disease.” Learn more about Borg’s research here: https://www.researchgate.net/profile/Rebecca_Borg2 Learn more about ALS here: https://bit.ly/ALSNewsToday…
https://www.youtube.com/watch?v=XJE8OxUn0d4 In this video by the Adaptive Canuck ALS Foundation, learn more about their work with families living with ALS and with adult stem cell research. Learn more about ALS here: https://bit.ly/ALSNewsToday…
ALS, or amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. A-myo-trophic comes from the Greek language. “A” means no. “Myo” is referring to the muscle, and “Trophic” means nourishment –…
ALS.net has just announced the launch of “ALS Unfiltered,” a series of public sessions that will offer expert-led presentations and open conversations about amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease), current research status, clinical trials, resources and other topics. The seminars will be held in several cities…
https://www.youtube.com/watch?v=emZjNcD484E In this Comcast NewsmakersIL video, learn more about the Les Turner ALS Foundation. “Since 1977, the Les Turner ALS Foundation has been Chicagoland’s leader in patient services, research, and education for Amyotrophic Lateral Sclerosis (ALS). The foundation serves nearly 90% of people living with ALS in the Chicagoland…
Yumanity Therapeutics has recently licensed a prodrug invented at the University of Arizona (UA), adding it to the company’s expanding platform of potential therapies for neurodegenerative diseases like amyotrophic lateral sclerosis (ALS). Neurodegenerative diseases result from errors made during the building and folding processes of proteins within the cell. In 2009, UA…
In this video by The University of Edinburgh, watch Chen Zhao from the School of Clinical Sciences present her three minute thesis entitled “Astrocyte: the Star of Motor Neuron Disease”. Learn more about ALS here: https://bit.ly/ALSNewsToday…
In this MND Australia video, “Kirsten Harley speaks about her experience living with motor neurone disease at Parliament House, Canberra, 24 February 2016.” Learn more about ALS here: https://bit.ly/ALSNewsToday…
